{"id":20053,"date":"2004-07-23T12:51:17","date_gmt":"2004-07-23T17:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=20053"},"modified":"2018-04-11T05:58:12","modified_gmt":"2018-04-11T10:58:12","slug":"20053","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/zh\/20053\/","title":{"rendered":"2004\u5e747\u670823\u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u7b80\u62a5"},"content":{"rendered":"<p><a target=\"_blank\" href=\"\/wp-content\/uploads\/2018\/01\/AHN-7-23-04.pdf\">\u6253\u5370\u7248\u672c<\/a><\/p>\n<p>*******************************************************************<br \/>\n&nbsp;<strong>Brakke \u54a8\u8be2\u516c\u53f8\u7684 <br \/>\n&nbsp;2004\u5e747\u670823\u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u7b80\u62a5<br \/>\n<\/strong>&nbsp;\u7248\u6743\u6240\u6709 \u00a9 Brakke \u54a8\u8be2\u516c\u53f8<br \/>\n&nbsp;*******************************************************************<br \/>\n\u65b0\u95fb\u62a5\u9053\uff1a<br \/>\n&nbsp;<br \/>\n<u>\u76c8\u5229\u65b0\u95fb<\/u>:<br \/>\nABAXIS<br \/>\n\u793c\u6765<br \/>\n\u9053\u5947\u5821<br \/>\n\u4e18\u9675<br \/>\n\u7231\u5fb7\u58eb<br \/>\n\u514d\u75ab\u7ec6\u80de<br \/>\n\u82f1\u7279\u5a01<br \/>\n\u7ebd\u91d1<br \/>\n\u96c0\u5de2 <br \/>\n\u8bfa\u534e<br \/>\n\u8f89\u745e<br \/>\n\u5148\u7075\u8446\u96c5<br \/>\n&nbsp;<br \/>\n&nbsp;<br \/>\n<u>\u5176\u4ed6\u65b0\u95fb<\/u>:<br \/>\n\u963f\u5c14\u6cd5\u739b<br \/>\n\u751f\u7269\u5236\u54c1<br \/>\n\u751f\u7269\u54e8\u5175<br \/>\n\u5df4\u7279\u52d2<br \/>\n\u7272\u755c\u9500\u552e<br \/>\nCowTek<br \/>\n\u675c\u90a6<br \/>\n\u519c\u573a\u8def<br \/>\n\u9053\u5947\u5821<br \/>\n\u57fa\u56e0<br \/>\n\u8c37\u7269\u52a0\u5de5\u516c\u53f8<br \/>\n\u83b1\u514b\u65af\u7279\u9f99<br \/>\n\u5965\u666e\u8482\u5e03\u5170\u5fb7<br \/>\n\u5e15\u62c9\u79d1\u6280<br \/>\n\u83f2\u5c3c\u514b\u65af\u79d1\u5b66<br \/>\n\u690d\u7269\u836f\u4e1a<br \/>\n\u5149\u8c31\u54c1\u724c<br \/>\n\u8054\u5408\u5de5\u4e1a<br \/>\n\u8054\u5408\u5ba0\u7269\u96c6\u56e2<br \/>\n\u7ea6\u514b\u90e1\u52a8\u7269\u4fdd\u5065<br \/>\n&nbsp;<br \/>\n******************************************************************<br \/>\n\u516c\u53f8\u4e1a\u7ee9\u53d1\u5e03<br \/>\n&nbsp;<br \/>\n&gt; \u8f89\u745e\u516c\u53f8\u516c\u5e03\u4e86\u622a\u81f3 2004 \u5e74 6 \u6708 30 \u65e5\u7684\u7b2c\u4e09\u5b63\u5ea6\u548c\u7b2c\u516d\u5b63\u5ea6\u7684\u4e1a\u7ee9\u3002\u5176\u52a8\u7269\u4fdd\u5065\u90e8\u95e8\u7b2c\u4e8c\u5b63\u5ea6\u7684\u6536\u5165\u4e3a $4.84 \u4ebf\u7f8e\u5143\uff0c\u6bd4 2003 \u5e74\u7b2c\u4e8c\u5b63\u5ea6\u589e\u52a0 26%\u3002\u4e0a\u534a\u5e74\u7684\u6536\u5165\u4e3a $9.12 \u4ebf\u7f8e\u5143\uff0c\u6bd4 2003 \u5e74\u4e0a\u534a\u5e74\u589e\u52a0 40%\u3002\u8f89\u745e\u516c\u53f8\u4e8e 2003 \u5e74 4 \u6708 16 \u65e5\u5b8c\u6210\u5bf9 Pharmacia \u7684\u6536\u8d2d\u3002\u9664\u4e86 Pharmacia \u6536\u8d2d\u7684\u5f71\u54cd\u5916\uff0cRimadyl\u3001Revolution \u548c Clavamox\/Synulox \u4ee5\u53ca\u725b\u751f\u7269\u5236\u54c1\u7684\u5f3a\u52b2\u8868\u73b0\uff0c\u4ee5\u53ca\u7f8e\u5143\u76f8\u5bf9\u4e8e\u4e0a\u4e00\u5e74\u8d70\u5f31\u7684\u6709\u5229\u5f71\u54cd\u4e5f\u63a8\u52a8\u4e86\u4e1a\u7ee9\u7684\u589e\u957f\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09 <br \/>\n&nbsp;<br \/>\n&gt; \u963f\u514b\u82cf\u8bfa\u8d1d\u5c14\u516c\u5e03\u4e86\u622a\u81f32004\u5e746\u670830\u65e5\u7684\u7b2c\u4e09\u5b63\u5ea6\u548c\u516d\u4e2a\u6708\u4e1a\u7ee9\u3002\u52a8\u7269\u4fdd\u5065\u96c6\u56e2\u82f1\u7279\u5a01\u5b9e\u73b0\u4e866%\u7684\u81ea\u4e3b\u589e\u957f\uff0c\u7b2c\u4e8c\u5b63\u5ea6\u9500\u552e\u989d\u8fbe2.54\u4ebf\u6b27\u5143\uff08$3.07\u4ebf\u6b27\u5143\uff09\u30022004\u5e74\u4e0a\u534a\u5e74\u9500\u552e\u989d\u4e3a5.11\u4ebf\u6b27\u5143\uff08$6.18\u4ebf\u6b27\u5143\uff09\uff0c\u800c2003\u5e74\u4e0a\u534a\u5e74\u4e3a4.96\u4ebf\u6b27\u5143\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n\u60e0\u6c0f\u516c\u5e03\u4e86\u622a\u81f32004\u5e746\u670830\u65e5\u7684\u7b2c\u4e09\u5b63\u5ea6\u548c\u516d\u4e2a\u6708\u4e1a\u7ee9\u3002\u798f\u7279\u9053\u5947\u52a8\u7269\u4fdd\u5065\u90e8\u95e8\u7b2c\u4e8c\u5b63\u5ea6\u6536\u5165\u4e3a12.39\u4ebf\u7f8e\u5143\uff0c\u8f832003\u5e74\u7b2c\u4e8c\u5b63\u5ea6\u589e\u957f1.21\u4ebf\u7f8e\u5143\u30022004\u5e74\u4e0a\u534a\u5e74\u6536\u5165\u4e3a14.58\u4ebf\u7f8e\u5143\uff0c\u8f832003\u5e74\u4e0a\u534a\u5e74\u589e\u957f1.61\u4ebf\u7f8e\u5143\u3002\u6536\u5165\u589e\u957f\u4e3b\u8981\u5f97\u76ca\u4e8eProHeart 6\u7684\u9500\u91cf\u589e\u957f\uff0c\u4f46\u90e8\u5206\u62b5\u6d88\u4e86\u897f\u5c3c\u7f57\u6cb3\u75c5\u6bd2\u75ab\u82d7\u9500\u91cf\u7684\u4e0b\u964d\u3002\u5254\u9664\u5916\u6c47\u5e26\u6765\u7684\u6709\u5229\u5f71\u54cd\uff0c2004\u5e74\u7b2c\u4e8c\u5b63\u5ea6\u6536\u5165\u589e\u957f1.01\u4ebf\u7f8e\u5143\uff0c\u4e0a\u534a\u5e74\u6536\u5165\u589e\u957f1.11\u4ebf\u7f8e\u5143\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u8bfa\u534e\u516c\u53f8\u62a5\u544a\u79f0\uff0c2004\u5e74\u4e0a\u534a\u5e74\uff0c\u5176\u52a8\u7269\u4fdd\u5065\u90e8\u95e8\u7684\u9500\u552e\u989d\u589e\u957f\u81f3143.53\u4ebf\u6cf0\u94e2\uff08\u7ea6\u54081.43\u4ebf\u7f8e\u5143\uff09\uff0c\u4ee5\u7f8e\u5143\u8ba1\u7b97\u589e\u957f413.53\u4ebf\u7f8e\u5143\uff0c\u4ee5\u5f53\u5730\u8d27\u5e01\u8ba1\u7b97\u4e0b\u964d213.53\u4ebf\u7f8e\u5143\uff0c\u8fd9\u4e3b\u8981\u5f52\u56e0\u4e8e2003\u5e74\u975e\u6218\u7565\u6027\u54c1\u724c\uff08Neocidol\u548cNuvan\uff09\u7684\u5265\u79bb\u3002\u5254\u9664\u6b64\u5f71\u54cd\uff0c\u6301\u7eed\u7ecf\u8425\u4e1a\u52a1\u4ee5\u7f8e\u5143\u8ba1\u7b97\u589e\u957f1413.53\u4ebf\u7f8e\u5143\uff0c\u4ee5\u5f53\u5730\u8d27\u5e01\u8ba1\u7b97\u589e\u957f713.53\u4ebf\u7f8e\u5143\u3002\u4e3b\u8981\u5728\u7f8e\u56fd\u548c\u6b27\u6d32\u5e02\u573a\u63a8\u51fa\u7684\u65b0\u578b\u4f34\u4fa3\u52a8\u7269\u4ea7\u54c1\u662f\u4e3b\u8981\u7684\u589e\u957f\u52a8\u529b\u3002\u519c\u573a\u52a8\u7269\u7279\u8bb8\u7ecf\u8425\u4e1a\u52a1\u7565\u6709\u4e0b\u964d\uff0c\u725b\u7f8a\u5bc4\u751f\u866b\u6740\u866b\u5242\u548c\u65b0\u578b\u519c\u573a\u8747\u7c7b\u9632\u6cbb\u836f\u7269\u7684\u589e\u957f\u4ec5\u90e8\u5206\u5f25\u8865\u4e86\u54c1\u724c\u5265\u79bb\u7684\u5f71\u54cd\u3002\u7b2c\u4e8c\u5b63\u5ea6\u8425\u4e1a\u6536\u5165\u98d9\u53472913.53\u4ebf\u7f8e\u5143\uff0c\u4e0a\u534a\u5e74\u8425\u4e1a\u5229\u6da6\u7387\u8fbe\u523011.613.53\u4ebf\u7f8e\u5143\u3002\u53d7\u6c47\u7387\u5f71\u54cd\uff0c\u8be5\u4e1a\u52a1\u7684\u8425\u4e1a\u6210\u672c\u6709\u6240\u589e\u52a0\uff0c\u4f46\u4ee5\u5f53\u5730\u8d27\u5e01\u8ba1\u7b97\u4ecd\u4e0e\u4e0a\u5e74\u6301\u5e73\u3002\uff08\u516c\u53f8\u901a\u8baf\uff09&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u793c\u6765\u516c\u53f8\u516c\u5e03\u4e86 2004 \u5e74\u7b2c\u4e8c\u5b63\u5ea6\u7684\u4e1a\u7ee9\u3002\u52a8\u7269\u4fdd\u5065\u90e8\u95e8 Elanco \u7684\u6536\u5165\u4e3a $1.8 \u4ebf\uff0c\u4e0e 2003 \u5e74\u7b2c\u4e8c\u5b63\u5ea6\u76f8\u6bd4\u589e\u957f\u4e86 8%\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u5148\u7075\u8446\u96c5\u516c\u53f8\u516c\u5e03\u4e862004\u5e74\u7b2c\u4e8c\u5b63\u5ea6\u7684\u8d22\u52a1\u4e1a\u7ee9\u30022004\u5e74\u7b2c\u4e8c\u5b63\u5ea6\uff0c\u52a8\u7269\u4fdd\u5065\u4ea7\u54c1\u9500\u552e\u989d\u603b\u8ba1141.86\u4ebf\u7f8e\u5143\uff0c\u540c\u6bd4\u589e\u957f91.33\u4ebf\u7f8e\u5143\uff0c\u5176\u4e2d\u5305\u62ec61.33\u4ebf\u7f8e\u5143\u7684\u6709\u5229\u5916\u6c47\u5f71\u54cd\u30022004\u5e74\u4e0a\u534a\u5e74\u9500\u552e\u989d\u4e3a141.356\u4ebf\u7f8e\u5143\uff0c\u8f832003\u5e74\u4e0a\u534a\u5e74\u589e\u957f141.33\u4ebf\u7f8e\u5143\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u7231\u5fb7\u58eb\u5b9e\u9a8c\u5ba4\u516c\u53f8 (IDEXX Laboratories Inc.) \u62a5\u544a\u79f0\uff0c\u622a\u81f3 2004 \u5e74 6 \u6708 30 \u65e5\u7684\u5b63\u5ea6\uff0c\u51c0\u5229\u6da6\u4ece\u53bb\u5e74\u540c\u671f\u7684 1,670 \u4e07\u7f8e\u5143\u589e\u81f3 4.31 \u4ebf\u7f8e\u5143\uff0c\u8fbe\u5230 2,390 \u4e07\u7f8e\u5143\u30022004 \u5e74\u7b2c\u4e8c\u5b63\u5ea6\u6536\u5165\u4ece 2003 \u5e74\u7b2c\u4e8c\u5b63\u5ea6\u7684 1.22 \u4ebf\u7f8e\u5143\u589e\u81f3 1.37 \u4ebf\u7f8e\u5143\u3002\u6c47\u7387\u7684\u5229\u597d\u56e0\u7d20\u4e3a\u6536\u5165\u589e\u957f\u8d21\u732e\u4e86 2.1 \u4ebf\u7f8e\u5143\u30022004 \u5e74\u7b2c\u4e8c\u5b63\u5ea6\u4f34\u4fa3\u52a8\u7269\u7ec4 (CAG) \u6536\u5165\u4ece 2003 \u5e74\u7b2c\u4e8c\u5b63\u5ea6\u7684 1.99 \u4ebf\u7f8e\u5143\u589e\u81f3 1.41 \u4ebf\u7f8e\u5143\uff0c\u8fbe\u5230 1.13 \u4ebf\u7f8e\u5143\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09 <br \/>\n&nbsp;<br \/>\n\u9ad8\u9732\u6d01\u68d5\u6984\u516c\u53f8\u516c\u5e03\u4e862004\u5e74\u7b2c\u4e8c\u5b63\u5ea6\u7684\u4e1a\u7ee9\u3002\u5e0c\u5c14\u601d\u5ba0\u7269\u8425\u517b\u90e8\u95e8\uff08\u5360\u516c\u53f8\u9500\u552e\u989d\u768414.1%\uff09\u5728\u53bb\u5e74\u540c\u671f\u5f3a\u52b2\u589e\u957f\u7684\u57fa\u7840\u4e0a\uff0c2004\u5e74\u7b2c\u4e8c\u5b63\u5ea6\u7684\u5355\u4f4d\u9500\u91cf\u589e\u957f\u4e864.01%\u3002\u7f8e\u5143\u9500\u552e\u989d\u4e0e2003\u5e74\u7b2c\u4e8c\u5b63\u5ea6\u76f8\u6bd4\u589e\u957f\u4e869.01%\uff0c\u8fbe\u52301.4355\u4ebf\u7f8e\u5143\uff0c\u8fd9\u53cd\u6620\u4e86\u9500\u91cf\u7684\u589e\u957f\u30013.01%\u7684\u6709\u5229\u5916\u6c47\u6c47\u7387\u4ee5\u53ca\u56fd\u5185\u4ef7\u683c\u4e0a\u6da8\u7684\u5f71\u54cd\u3002\u7531\u4e8e\u5546\u4e1a\u6295\u8d44\u589e\u52a0\uff0c\u7b2c\u4e8c\u5b63\u5ea6\u7684\u7f8e\u5143\u8425\u4e1a\u5229\u6da6\u589e\u957f\u4e869.01%\uff0c\u8fbe\u52301.499\u4ebf\u7f8e\u5143\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; Neogen \u516c\u53f8\u62a5\u544a\u79f0\uff0c\u622a\u81f3 5 \u6708 31 \u65e5\u7684 2004 \u8d22\u5e74\uff0c\u516c\u53f8\u6536\u5165\u589e\u957f\u4e86 16.1 \u4ebf\u7f8e\u5143\uff0c\u5ef6\u7eed\u4e86\u516c\u53f8\u5b63\u5ea6\u76c8\u5229\u548c\u6536\u5165\u589e\u957f\u7684\u4f18\u5f02\u8bb0\u5f55\u30022004 \u8d22\u5e74\u6536\u5165\u4e3a 14.55 \u4ebf\u7f8e\u5143\uff0c\u800c 2003 \u8d22\u5e74\u4e3a 14.77 \u4ebf\u7f8e\u5143\u3002\u5c3d\u7ba1\u7b2c\u56db\u5b63\u5ea6\u975e\u7ecf\u5e38\u6027\u652f\u51fa\u4e3a 14.30 \u4e07\u7f8e\u5143\uff0c\u7528\u4e8e\u6574\u5408\u8fd0\u8425\u5e76\u5927\u5e45\u524a\u51cf\u672a\u6765\u8fd0\u8425\u6210\u672c\uff0cNeogen \u4ecd\u62a5\u544a\u51c0\u5229\u6da6\u4e3a 14.51 \u4ebf\u7f8e\u5143\uff0c\u6bd4\u4e0a\u4e00\u5e74\u589e\u957f\u4e86 6.51 \u4ebf\u7f8e\u5143\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; ABAXIS\u516c\u53f8\u516c\u5e03\u4e86\u622a\u81f32004\u5e746\u670830\u65e5\u7684\u7b2c\u4e00\u8d22\u5b63\u521b\u7eaa\u5f55\u7684\u8d22\u52a1\u4e1a\u7ee9\u3002\u7b2c\u4e00\u8d22\u5b63\uff0cABAXIS\u8425\u6536\u8fbe\u521b\u7eaa\u5f55\u76841320\u4e07\u7f8e\u5143\uff0c\u800c\u53bb\u5e74\u540c\u671f\u8425\u6536\u4e3a1030\u4e07\u7f8e\u5143\uff0c\u540c\u6bd4\u589e\u957f2.81\u4ebf\u7f8e\u5143\u3002\u516c\u53f8\u62a5\u544a\u79f0\uff0c\u5f52\u5c5e\u4e8e\u666e\u901a\u80a1\u80a1\u4e1c\u7684\u51c0\u5229\u6da6\u4e3a140\u4e07\u7f8e\u5143\uff0c\u800c\u53bb\u5e74\u540c\u671f\u4e3a65.9\u4e07\u7f8e\u5143\uff0c\u540c\u6bd4\u589e\u957f11.81\u4ebf\u7f8e\u5143\u3002\u672c\u5b63\u5ea6\u51c0\u5229\u6da6\u7684\u5b9e\u73b0\u5f97\u76ca\u4e8e2003\u5e7410\u6708D\u7cfb\u5217\u548cE\u7cfb\u5217\u4f18\u5148\u80a1\u8f6c\u6362\u4e3a\u666e\u901a\u80a1\uff0c\u4ece\u800c\u514d\u9664\u4e86\u516c\u53f8\u5728\u622a\u81f32004\u5e746\u670830\u65e5\u7684\u5b63\u5ea6\u6d3e\u53d1\u4f18\u5148\u80a1\u80a1\u606f\u7684\u4e49\u52a1\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; ImmuCell Corporation \u5ba3\u5e03\u4e86\u622a\u81f3 2004 \u5e74 6 \u6708 30 \u65e5\u7684\u4e09\u4e2a\u6708\u7684\u7ecf\u8425\u4e1a\u7ee9\u3002\u622a\u81f3 2004 \u5e74 6 \u6708 30 \u65e5\u7684\u4e09\u4e2a\u6708\uff0c\u4ea7\u54c1\u9500\u552e\u989d\u4e0e 2003 \u5e74\u540c\u671f\u76f8\u6bd4\u589e\u52a0\u4e86 9%\uff0c\u8fbe\u5230 $642,000\u3002\u622a\u81f3 2004 \u5e74 6 \u6708 30 \u65e5\u7684\u4e09\u4e2a\u6708\uff0c\u516c\u53f8\u786e\u8ba4\u51c0\u4e8f\u635f\u4e3a ($58,000)\uff0c\u800c 2003 \u5e74\u540c\u671f\u7684\u51c0\u4e8f\u635f\u4e3a ($124,000)\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09 <br \/>\n&nbsp;<br \/>\n&gt; \u96c0\u5de2\u516c\u5e03\uff0c\u5176\u5ba0\u7269\u62a4\u7406\u90e8\u95e82004\u5e74\u7b2c\u4e00\u5b63\u5ea6\u7684\u9500\u552e\u989d\u4e3a24\u4ebf\u745e\u58eb\u6cd5\u90ce\uff08$19\u4ebf\uff09\uff0c\u4e0e2003\u5e74\u7b2c\u4e00\u5b63\u5ea6\u76f8\u6bd4\uff0c\u6709\u673a\u589e\u957f\u4e869%\u3002\u8be5\u516c\u53f8\u5c06\u9500\u552e\u989d\u7684\u589e\u957f\u5f52\u529f\u4e8e\u5ba0\u7269\u98df\u54c1\u5e02\u573a\u7684\u5f3a\u52b2\u589e\u957f\u3002\uff08\u52a8\u7269\u5236\u836f\uff09 <br \/>\n&nbsp;<br \/>\n******************************************************************<br \/>\n\u60f3\u77e5\u9053\u60a8\u7684\u5ba2\u6237\u5728\u60f3\u4ec0\u4e48\u5417\uff1f<br \/>\n&nbsp;<br \/>\nBrakke Consulting \u62e5\u6709\u4e13\u6709\u6570\u636e\u5e93\uff0c\u5176\u4e2d\u5305\u542b\u8d85\u8fc7 1,000 \u540d\u5c0f\u52a8\u7269\u517d\u533b\u4ee5\u53ca\u6570\u767e\u540d\u9a6c\u79d1\u517d\u533b\uff0c\u53ef\u7528\u4e8e\u5e02\u573a\u8c03\u7814\u9879\u76ee\u3002\u8c03\u67e5\u53ef\u4ee5\u901a\u8fc7\u7f51\u7edc\u6216\u4f20\u771f\u8fdb\u884c\uff0c\u5468\u671f\u4e0d\u5230\u4e00\u4e2a\u6708\u3002\u6211\u4eec\u8fd8\u63d0\u4f9b\u5229\u7528\u8d35\u516c\u53f8\u5ba2\u6237\u540d\u5355\u8fdb\u884c\u5e02\u573a\u8c03\u7814\u7684\u529f\u80fd\u3002&nbsp; <br \/>\n&nbsp;<br \/>\n\u5982\u679c\u60a8\u6b63\u5728\u5bfb\u627e\u4fe1\u606f\u6765\u5e2e\u52a9\u5236\u5b9a\u8425\u9500\u8ba1\u5212\uff0c\u6216\u8003\u8651\u63a8\u51fa\u65b0\u4ea7\u54c1\uff0c\u6211\u4eec\u53ef\u4ee5\u4e3a\u60a8\u63d0\u4f9b\u51b3\u5b9a\u60a8\u6210\u529f\u7684\u4eba\u5458\u7684\u6700\u65b0\u53cd\u9988\u3002&nbsp; <br \/>\n&nbsp; <br \/>\n\u5982\u9700\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u81f4\u7535 972-243-4033 \u6216\u53d1\u9001\u7535\u5b50\u90ae\u4ef6\u81f3 Lynn Fondon <a href=\"mailto:lfondon@brakkeconsulting.com\">lfondon@brakkeconsulting.com<\/a>. <br \/>\n&nbsp;<br \/>\n******************************************************************<br \/>\n\u516c\u53f8\u65b0\u95fb\u7a3f<br \/>\n&nbsp;<br \/>\n&gt; Alpharma Inc. \u5ba3\u5e03\u5df2\u5b8c\u6210\u5c06\u5176\u52a8\u7269\u4fdd\u5065\u4e1a\u52a1\u4e2d\u7684\u6c34\u751f\u52a8\u7269\u4fdd\u5065\u4e1a\u52a1\u51fa\u552e\u7ed9\u4e00\u4e2a\u5458\u5de5\u56e2\u4f53\u3002\u8be5\u6c34\u751f\u52a8\u7269\u4fdd\u5065\u4e1a\u52a1\u603b\u90e8\u4f4d\u4e8e\u632a\u5a01\u5965\u65af\u9646\uff0c\u4e3b\u8981\u751f\u4ea7\u548c\u9500\u552e\u7528\u4e8e\u5168\u7403\u517b\u6b96\u9c7c\u7c7b\u514d\u75ab\u7684\u75ab\u82d7\u3002\u6b64\u6b21\u4ea4\u6613\u7684\u9500\u552e\u4ef7\u683c\u9884\u8ba1\u7ea6\u4e3a14\u4ebf\u6b27\u5143\uff0c\u57fa\u4e8e\u6c34\u751f\u52a8\u7269\u4fdd\u5065\u4e1a\u52a1\u7684\u8425\u8fd0\u8d44\u672c\u3002\u6b64\u5916\uff0c\u8be5\u534f\u8bae\u8fd8\u5305\u62ec\u6839\u636e\u672a\u6765\u6c34\u751f\u52a8\u7269\u4fdd\u5065\u4e1a\u52a1\u7684\u6536\u76ca\u5411 Alpharma \u652f\u4ed8\u7684\u6f5c\u5728\u672a\u6765\u6b3e\u9879\uff0c\u4ee5\u53ca\u4e70\u65b9\u627f\u62c5\u67d0\u4e9b\u503a\u52a1\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09&nbsp;&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40 (FDA) \u4fee\u8ba2\u4e86\u52a8\u7269\u836f\u54c1\u6cd5\u89c4\uff0c\u4ee5\u53cd\u6620\u83f2\u5c3c\u514b\u65af\u79d1\u5b66\u516c\u53f8 (Phoenix Scientific, Inc.) \u63d0\u4ea4\u7684\u7b80\u5316\u65b0\u52a8\u7269\u836f\u54c1\u7533\u8bf7 (ANADA) \u7684\u6279\u51c6\u3002ANADA \u89c4\u5b9a\uff0c\u517d\u533b\u5904\u65b9\u53ef\u4ee5\u4f7f\u7528\u5480\u56bc\u4f0a\u7ef4\u83cc\u7d20\u7247\u7ed9\u72ac\u4f7f\u7528\uff0c\u901a\u8fc7\u6d88\u706d\u72ac\u5fc3\u4e1d\u866b\u5e7c\u866b\u5728\u611f\u67d3\u540e\u4e00\u4e2a\u6708\u5185\u5f62\u6210\u7684\u7ec4\u7ec7\u9636\u6bb5\u6765\u9884\u9632\u72ac\u5fc3\u4e1d\u866b\u75c5\u3002\uff08AnimalNet - \u8054\u90a6\u516c\u62a5\uff09&nbsp;&nbsp;&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u9053\u5947\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u5ba3\u5e03\u63a8\u51fa Fel-O-Vax Lv-K\/FIV \u732b\u75ab\u82d7\uff0c\u8be5\u75ab\u82d7\u53ef\u63d0\u4f9b\u7ecf\u9a8c\u8bc1\u7684\u9488\u5bf9\u732b\u767d\u8840\u75c5\u75c5\u6bd2 (FeLV) \u548c\u732b\u514d\u75ab\u7f3a\u9677\u75c5\u6bd2 (FIV) \u7684\u4fdd\u62a4\u3002FeLV \u6210\u5206\u662f\u4e00\u79cd\u5168\u75c5\u6bd2\u75ab\u82d7\uff0c\u5305\u542b\u5b8c\u6574\u767d\u8840\u75c5\u75c5\u6bd2\u7684\u5173\u952e\u6297\u539f\u5143\u4ef6\uff0c\u53ef\u523a\u6fc0\u5b8c\u5168\u6297\u4f53\u53cd\u5e94\u3002FIV \u6210\u5206\u5305\u542b\u591a\u4e2a\u8fdb\u5316\u679d\uff0c\u53ef\u63d0\u4f9b\u9488\u5bf9\u8be5\u75be\u75c5\u7684\u5e7f\u6cdb\u4ea4\u53c9\u4fdd\u62a4\uff0c\u4ee5\u53ca\u9488\u5bf9 B \u8fdb\u5316\u679d\u7684\u4ea4\u53c9\u4fdd\u62a4\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u5df4\u7279\u52d2\u516c\u53f8\u5ba3\u5e03\uff0c\u5ba0\u7269\u6551\u52a9\u57fa\u91d1\u4f1a\u5df2\u9009\u62e9\u5df4\u7279\u52d2\u4f5c\u4e3a\u5176\u5408\u4f5c\u91c7\u8d2d\u9879\u76ee\u7684\u4e3b\u8981\u52a8\u7269\u4fdd\u5065\u4f9b\u5e94\u5546\u3002\u5c3d\u7ba1\u5df4\u7279\u52d2\u516c\u53f8\u4e3b\u8981\u5411\u517d\u533b\u8bca\u6240\u5206\u9500\u4ea7\u54c1\uff0c\u4f46\u6b64\u6b21\u5408\u4f5c\u4e5f\u8981\u6c42\u5df4\u7279\u52d2\u5411\u52a8\u7269\u6536\u5bb9\u6240\u548c\u4eba\u9053\u534f\u4f1a\u5206\u9500\u4ea7\u54c1\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; Bioproducts Inc. \u5ba3\u5e03\uff0c\u8ba1\u5212\u5265\u79bb\u5176\u6c2f\u5316\u80c6\u78b1\u4e1a\u52a1\uff0c\u8f6c\u800c\u4e13\u6ce8\u4e8e\u5176\u4ed6\u52a8\u7269\u8425\u517b\u4e1a\u52a1\u3002Bioproducts \u7684\u5176\u4ed6\u4e1a\u52a1\u5305\u62ec\u8425\u517b\u6027\u5976\u725b\u9972\u6599\u539f\u6599\u3002\uff08\u9972\u6599\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; Optibrand, Ltd. \u548c Lextron, Inc. \u5ba3\u5e03\u8fbe\u6210\u534f\u8bae\uff0cLextron \u5c06\u6210\u4e3a Optibrand \u901a\u7528\u7272\u755c\u8bc6\u522b\u548c\u6570\u636e\u6536\u96c6\u6280\u672f\u7684\u6388\u6743\u5206\u9500\u5546\u548c\u7ecf\u9500\u5546\u3002Lextron \u7684\u9500\u552e\u56e2\u961f\u5c06\u4e3a Optibrand \u63d0\u4f9b\u8986\u76d6\u5168\u7f8e\u5404\u5730\u7684\u5173\u952e\u6bcd\u725b\/\u5c0f\u725b\u548c\u9972\u517b\u573a\u9886\u57df\u7684\u670d\u52a1\u3002Optibrand \u662f\u5168\u7403\u552f\u4e00\u57fa\u4e8e\u89c6\u7f51\u819c\u626b\u63cf\u6280\u672f\u7684\u901a\u7528\u52a8\u7269\u8eab\u4efd\u8bc6\u522b\u7cfb\u7edf\u7684\u521b\u59cb\u4eba\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09&nbsp;&nbsp;&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; CattleSale Co. \u5ba3\u5e03\u5b8c\u6210\u5bf9 CowTek, Inc. \u7684\u6536\u8d2d\u3002CowTek \u63d0\u4f9b\u7b26\u5408 ISO \u6807\u51c6\u7684\u8bb0\u5fc6\u6807\u7b7e\u6280\u672f\uff0c\u53ef\u8bc6\u522b\u5355\u4e2a\u52a8\u7269\uff0c\u5e76\u53ef\u4ece\u519c\u573a\u5230\u5c60\u5bb0\u5168\u7a0b\u8ffd\u8e2a\uff0c\u5e76\u53ef\u8fdb\u884c\u4fee\u6539\uff0c\u4ee5\u8ffd\u8e2a\u8089\u7c7b\u4ea7\u54c1\u4ece\u5c60\u5bb0\u573a\u5230\u96f6\u552e\u5e97\u7684\u5168\u8fc7\u7a0b\u3002\u6b64\u6b21\u6536\u8d2d\u4ee5\u80a1\u7968\u7f6e\u6362\u7684\u65b9\u5f0f\u8fdb\u884c\uff0c\u4f30\u503c 1421 \u4e07\u7f8e\u5143\u3002CowTek \u5c06\u4f5c\u4e3a CattleSale \u7684\u4e00\u4e2a\u90e8\u95e8\u8fd0\u8425\uff0c\u5e76\u5c06\u7ee7\u7eed\u5728\u5185\u5e03\u62c9\u65af\u52a0\u5dde\u7684\u73b0\u6709\u529e\u516c\u5730\u70b9\u8fd0\u8425\uff0c\u7531\u73b0\u4efb\u9996\u5e2d\u6267\u884c\u5b98\u517c\u603b\u88c1 Gary Marsh \u9886\u5bfc\u3002(Feedstuffs)&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u8054\u5408\u5de5\u4e1a\u516c\u53f8\uff08United Industries Corp\uff0c\u53c8\u540dSpectrum Brands\uff09\u5ba3\u5e03\uff0c\u5df2\u8fbe\u6210\u534f\u8bae\uff0c\u5c06\u4ee5143.6\u4ebf\u7f8e\u5143\u6536\u8d2d\u8054\u5408\u5ba0\u7269\u96c6\u56e2\uff08United Pet Group\uff09\u3002\u8054\u5408\u5ba0\u7269\u76ee\u524d\u7531\u79c1\u52df\u80a1\u6743\u96c6\u56e2TA Associates\u548cFriend Skoler &amp; Co.\u6240\u6709\uff0c\u4f46\u4f5c\u4e3a\u4e00\u5bb6\u72ec\u7acb\u7684\u5ba0\u7269\u516c\u53f8\u8fd0\u8425\u3002\u8054\u5408\u5ba0\u7269\u65d7\u4e0b\u54c1\u724c\u5305\u62ecEight in One\u548cNature&#039;s Miracle\u3002John Heil\u5c06\u7ee7\u7eed\u62c5\u4efb\u8054\u5408\u5ba0\u7269\u96c6\u56e2\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98\u3002\u9884\u8ba1\u8be5\u4ea4\u6613\u5c06\u4e8e8\u6708\u5b8c\u6210\u3002\uff08\u5ba0\u7269\u4ea7\u54c1\u65b0\u95fb\uff09 <br \/>\n&nbsp;<br \/>\n&gt; Grain Processing Corp. (GPC) \u5ba3\u5e03\u6210\u7acb GPC Pet Products \u516c\u53f8\uff0c\u4ee5\u6269\u5927\u5176\u5ba0\u7269\u5e02\u573a\u5730\u4f4d\u3002\u65b0\u516c\u53f8\u5c06\u4e13\u6ce8\u4e8e\u6269\u5c55\u201c\u5168\u7403\u6700\u4f73\u732b\u7802\u201d\u7cfb\u5217\u3001\u5f00\u53d1\u65b0\u7684\u5ba0\u7269\u4ea7\u54c1\u4ee5\u53ca\u8fdb\u884c\u6218\u7565\u6027\u6536\u8d2d\u3002\uff08\u5ba0\u7269\u4ea7\u54c1\u65b0\u95fb\uff09&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\nPala-Tech Laboratories \u5ba3\u5e03\u63a8\u51fa\u72ac\u5173\u8282\u5065\u5eb7\u8f6f\u5480\u56bc\u7247\uff0c\u8fd9\u662f\u4e00\u6b3e\u8089\u5473\u81b3\u98df\u8865\u5145\u5242\uff0c\u542b\u6709\u8461\u8404\u7cd6\u80fa\u3001\u808c\u9178\u548c MSM\u3002\u8fd9\u6b3e\u8f6f\u5480\u56bc\u7247\u662f\u5bf9\u516c\u53f8\u73b0\u6709\u81b3\u98df\u8865\u5145\u5242\u4ea7\u54c1\u7ebf\u7684\u8865\u5145\u3002\uff08\u52a8\u7269\u5236\u836f\uff09 <br \/>\n&nbsp;<br \/>\n&gt; \u675c\u90a6\u516c\u53f8\u5ba3\u5e03\u5df2\u6536\u8d2d\u6d88\u6bd2\u5242\u516c\u53f8BioSentry Inc.\u7684\u52a8\u7269\u4fdd\u5065\u4e1a\u52a1\u8d44\u4ea7\u3002\u5177\u4f53\u8d22\u52a1\u6761\u6b3e\u5c1a\u672a\u62ab\u9732\u3002\uff08Pig e-News\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n\u82f1\u56fd\u519c\u4ea7\u54c1\u5206\u9500\u5546 Farmway \u5ba3\u5e03\u6536\u8d2d\u517d\u836f\u5206\u9500\u5546 Yorkshire Animal Health\u3002Yorkshire Animal Health \u7684\u521b\u59cb\u4eba\u5c06\u7ee7\u7eed\u62c5\u4efb\u8be5\u90e8\u95e8\u7684\u9ad8\u7ea7\u7ba1\u7406\u5c42\u3002\u8d22\u52a1\u6761\u6b3e\u5c1a\u672a\u62ab\u9732\u3002\uff08Animal Pharm\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; EU Phytopharm \u5ba3\u5e03\u63a8\u51fa\u5176\u7b2c\u4e8c\u6b3e\u517d\u836f\u4ea7\u54c1\uff0c\u7531 Genitrix \u4ee3\u7406\u9500\u552e\u3002\u8be5\u4ea7\u54c1\u540d\u4e3a Zanthofen\uff0c\u901a\u8fc7\u963b\u65ad COX-2 \u9176\u7684\u4ea7\u751f\uff0c\u5e2e\u52a9\u7ef4\u6301\u72ac\u5173\u8282\u6d3b\u52a8\u80fd\u529b\u3002Genitrix \u5c06\u4ee5\u81ea\u6709\u54c1\u724c\u9500\u552e\u8be5\u4ea7\u54c1\uff0c\u5e76\u6b63\u5728\u5bfb\u627e\u6b27\u6d32\u7ecf\u9500\u5546\u3002\uff08\u52a8\u7269\u5236\u836f\uff09&nbsp;&nbsp;&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\n********************************************************************<br \/>\n\u52a8\u7269\u5065\u5eb7\u65b0\u95fb<br \/>\n&nbsp;<br \/>\n&gt; \u610f\u5927\u5229\u3001\u65af\u6d1b\u6587\u5c3c\u4e9a\u2014\u2014\u75af\u725b\u75c5 \u8fc7\u53bb\u4e00\u5468\uff0c\u610f\u5927\u5229\u548c\u65af\u6d1b\u6587\u5c3c\u4e9a\u5206\u522b\u53d1\u73b0\u4e86\u4e24\u4f8b\u65b0\u7684\u3001\u4e92\u4e0d\u76f8\u5173\u7684\u75af\u725b\u75c5\u75c5\u4f8b\u3002\u8fd9\u4e9b\u75c5\u4f8b\u662f\u5728\u5f3a\u5236\u6027\u68c0\u6d4b\u4e2d\u53d1\u73b0\u7684\u3002\u8fd9\u662f\u610f\u5927\u5229\u4eca\u5e74\u786e\u8bca\u7684\u7b2c\u4e94\u4f8b\u75af\u725b\u75c5\u75c5\u4f8b\uff0c\u4e5f\u662f\u65af\u6d1b\u6587\u5c3c\u4e9a\u53d1\u73b0\u7684\u7b2c\u56db\u4f8b\u75af\u725b\u75c5\u75c5\u4f8b\u3002\u636e\u62a5\u9053\uff0c\u8fd9\u5934\u53d7\u611f\u67d3\u7684\u65af\u6d1b\u6587\u5c3c\u4e9a\u5976\u725b\u662f\u4ece\u5fb7\u56fd\u8fdb\u53e3\u7684\u3002\u65af\u6d1b\u6587\u5c3c\u4e9a\u4e8e5\u6708\u52a0\u5165\u6b27\u76df\u3002\uff08Meating Place\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u82ac\u5170\u2014\u2014\u5916\u6765\u7ebd\u5361\u65af\u5c14\u75ab\u60c5 \u82ac\u5170\u897f\u6d77\u5cb8\u4e00\u5bb6\u706b\u9e21\u517b\u6b96\u573a\u53d1\u73b0\u4e86\u5916\u6765\u7ebd\u5361\u65af\u5c14\u75ab\u60c5\u3002\u8be5\u517b\u6b96\u573a\u4f4d\u4e8e\u8d6b\u5c14\u8f9b\u57fa\u897f\u5317\u7ea6155\u82f1\u91cc\u5904\uff0c\u6240\u6709\u53d7\u5f71\u54cd\u7684\u706b\u9e21\u90fd\u5df2\u88ab\u5bb0\u6740\u9500\u6bc1\uff0c\u517b\u6b96\u573a\u4e5f\u5c06\u8fdb\u884c\u9694\u79bb\u548c\u6d88\u6bd2\u3002\u8fd9\u79cd\u75be\u75c5\u53c8\u79f0\u8111\u6c14\u708e\uff0c\u662f\u5728\u5e38\u89c4\u68c0\u6d4b\u4e2d\u53d1\u73b0\u7684\u3002\u8be5\u75c5\u4e0a\u6b21\u5728\u82ac\u5170\u51fa\u73b0\u662f\u57281996\u5e74\u3002\uff08Meating Place\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u745e\u5178\u2014\u2014\u65b0\u57ce\u75ab \u745e\u5178\u4e1c\u5357\u90e8\u4e24\u5bb6\u79bd\u517b\u6b96\u573a\u786e\u8bca\u611f\u67d3\u65b0\u57ce\u75ab\u3002\u5176\u4e2d\u4e00\u5bb6\u517b\u6b96\u573a\u670942900\u53ea\u86cb\u9e21\uff0c\u90bb\u8fd1\u4e00\u5bb6\u5546\u4e1a\u519c\u573a\u670930500\u53ea\u86cb\u9e21\u3002\u4e24\u5bb6\u517b\u6b96\u573a\u5747\u5df2\u6251\u6740\u6240\u6709\u9e21\u53ea\uff0c\u4ee5\u63a7\u5236\u75ab\u60c5\u3002\uff08\u52a8\u7269\u7f51\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u5370\u5ea6\u5c3c\u897f\u4e9a\u2014\u2014\u79bd\u6d41\u611f \u5370\u5ea6\u5c3c\u897f\u4e9a\u653f\u5e9c\u5ba3\u5e03\u5927\u89c4\u6a21\u5f00\u5c55\u9e21\u7fa4\u514d\u75ab\u63a5\u79cd\u6d3b\u52a8\uff0c\u4ee5\u5e94\u5bf9\u8be5\u56fd\u90e8\u5206\u5730\u533a\u51fa\u73b0\u65b0\u7684\u79bd\u6d41\u611f\u75c5\u4f8b\u3002\u519c\u4e1a\u90e8\u4e00\u4f4d\u5b98\u5458\u8bc1\u5b9e\uff0c\u672c\u6708\u4e1c\u722a\u54c7\u7701\u591a\u4e2a\u5730\u533a\u6709\u6570\u5343\u53ea\u9e21\u6b7b\u4ea1\u3002\u56e0\u6b64\uff0c\u653f\u5e9c\u8ba1\u5212\u5411\u5bb6\u79bd\u517b\u6b96\u573a\u53d1\u653e\u591a\u8fbe3\u4ebf\u5242\u75ab\u82d7\u3002\u5370\u5ea6\u5c3c\u897f\u4e9a\u4e0e\u8d8a\u5357\u3001\u4e2d\u56fd\u548c\u6cf0\u56fd\u4e00\u6837\uff0c\u8fd1\u671f\u90fd\u51fa\u73b0\u4e86\u79bd\u6d41\u611f\u75ab\u60c5\u7684\u590d\u53d1\u3002\uff08Meating Place\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd\u2014\u2014\u300a\u5c0f\u52a8\u7269\u7528\u9014\u548c\u5c0f\u52a8\u7269\u7269\u79cd\u5065\u5eb7\u6cd5\u6848\u300b\uff08MUMS\uff09\u5df2\u83b7\u7f8e\u56fd\u4f17\u8bae\u9662\u901a\u8fc7\u3002\u8be5\u6cd5\u6848\u73b0\u63d0\u4ea4\u5e03\u4ec0\u603b\u7edf\u7b7e\u7f72\u3002MUMS\u6cd5\u6848\u4e3a\u5236\u836f\u516c\u53f8\u63d0\u4f9b\u4e86\u591a\u9879\u65b0\u7684\u6fc0\u52b1\u63aa\u65bd\uff0c\u9f13\u52b1\u5176\u6295\u5165\u8d44\u6e90\u7528\u4e8e\u5c0f\u52a8\u7269\u7269\u79cd\u836f\u7269\u7814\u53d1\u4ee5\u53ca\u4e3b\u8981\u7269\u79cd\u7684\u5c0f\u52a8\u7269\u7528\u9014\u836f\u7269\u7814\u53d1\uff0c\u5305\u62ec\u6709\u6761\u4ef6\u7684\u836f\u7269\u5ba1\u6279\u4ee5\u53ca\u5408\u6cd5\u4e0a\u5e02\u7684\u672a\u83b7\u6279\u51c6\u836f\u7269\u7d22\u5f15\uff08\u836f\u7269\u7d22\u5f15\uff09\u3002\u8be5\u6cd5\u6848\u8fd8\u8bbe\u7acb\u4e86\u4e00\u4e2a\u65b0\u7684\u201c\u5c0f\u52a8\u7269\u7528\u9014\u548c\u5c0f\u52a8\u7269\u7269\u79cd\u836f\u7269\u7814\u53d1\u529e\u516c\u5ba4\u201d\u3002\uff08\u7f8e\u56fd\u517d\u533b\u534f\u4f1a\u65b0\u95fb\u7a3f\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd\u2014\u2014\u75af\u725b\u75c5\u9884\u6d4b \u6839\u636e\u6570\u5b66\u6a21\u578b\uff0c\u7f8e\u56fd\u5c06\u51fa\u73b0\u66f4\u591a\u75af\u725b\u75c5\u75c5\u4f8b\u3002\u7136\u800c\uff0c\u660e\u5c3c\u82cf\u8fbe\u5927\u5b66\u52a8\u7269\u5065\u5eb7\u4e0e\u98df\u54c1\u5b89\u5168\u4e2d\u5fc3\u7684\u75af\u725b\u75c5\u4e13\u5bb6\u5a01\u5c14\u00b7\u4f11\u65af\u987f\u535a\u58eb\u8868\u793a\uff0c\u4e0e20\u4e16\u7eaa80\u5e74\u4ee3\u672b\u81f390\u5e74\u4ee3\u521d\u6b27\u6d32\u53d1\u73b0\u7684\u75af\u725b\u75c5\u75c5\u4f8b\u76f8\u6bd4\uff0c\u7f8e\u56fd\u75af\u725b\u75c5\u75c5\u4f8b\u6570\u91cf\u5c06\u5f88\u5c0f\u3002\u4f11\u65af\u987f\u535a\u58eb\u8ba4\u4e3a\uff0c\u7f8e\u56fd\u7684\u75af\u725b\u75c5\u75c5\u4f8b\u6570\u91cf\u8f83\u4f4e\uff0c\u662f\u56e0\u4e3a\u7f8e\u56fd\u519c\u4e1a\u90e8\u4e8e1997\u5e74\u4e0b\u4ee4\u5b9e\u65bd\u4e86\u4e00\u9879\u5173\u952e\u7684\u9632\u706b\u5899\u63aa\u65bd\uff08\u4ece\u725b\u3001\u7f8a\u548c\u5c71\u7f8a\u9972\u6599\u4e2d\u53bb\u9664\u7279\u5b9a\u98ce\u9669\u7269\u8d28\uff0c\u4e3b\u8981\u662f\u53cd\u520d\u52a8\u7269\u86cb\u767d\uff09\u3002(Wattnet Meatnews)<br \/>\n&nbsp;<br \/>\n&gt; \u65e5\u7f8e\u2014\u2014\u75af\u725b\u75c5\u68c0\u6d4b\u89c4\u5219 \u7ecf\u8fc7\u6570\u6708\u7684\u8ba8\u8bba\uff0c\u65e5\u7f8e\u79d1\u5b66\u5bb6\u6700\u7ec8\u540c\u610f\u5efa\u8bae\u505c\u6b62\u5bf9\u5e7c\u725b\u548c\u65b0\u751f\u725b\u8fdb\u884c\u75af\u725b\u75c5\u68c0\u6d4b\uff0c\u8fd9\u4e00\u59a5\u534f\u6216\u5c06\u91cd\u542f\u4e24\u56fd\u725b\u8089\u8d38\u6613\u3002\u53cc\u65b9\u79d1\u5b66\u5bb6\u5f97\u51fa\u7ed3\u8bba\uff0c\u5728\u5bf930\u4e2a\u6708\u4ee5\u4e0b\u725b\u7684\u68c0\u6d4b\u4e2d\uff0c\u7591\u4f3c\u5bfc\u81f4\u75af\u725b\u75c5\u7684\u670a\u75c5\u6bd2\u5e76\u672a\u88ab\u53d1\u73b0\u3002\u79d1\u5b66\u5bb6\u4eec\u5728\u4e00\u4efd\u63d0\u4ea4\u7ed9\u4e1c\u4eac\u548c\u534e\u76db\u987f\u7684\u62a5\u544a\u4e2d\u63d0\u51fa\u4e86\u8fd9\u9879\u5efa\u8bae\uff0c\u8be5\u62a5\u544a\u662f\u5728\u4e3a\u671f\u4e24\u5929\u7684\u4f1a\u8c08\u7ed3\u675f\u65f6\u63d0\u51fa\u7684\uff0c\u65e8\u5728\u89e3\u51b3\u75af\u725b\u75c5\u4fdd\u969c\u63aa\u65bd\u65b9\u9762\u7684\u4e89\u7aef\u3002\u65e5\u672c\u4ee5\u81ea\u8eab\u5df2\u5bf9\u75af\u725b\u75c5\u8fdb\u884c\u5168\u9762\u68c0\u6d4b\u4e3a\u7531\uff0c\u62d2\u7edd\u89e3\u9664\u5bf9\u7f8e\u56fd\u725b\u8089\u7684\u8fdb\u53e3\u7981\u4ee4\uff0c\u9664\u975e\u7f8e\u56fd\u5bf9\u6240\u6709\u5c60\u5bb0\u7684\u98df\u7528\u725b\u8fdb\u884c\u68c0\u6d4b\u3002\uff08\u7f8e\u8054\u793e\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u745e\u58eb\u2014\u2014\u5ba0\u7269\u690d\u5165\u82af\u7247 \u745e\u58eb\u8054\u90a6\u59d4\u5458\u4f1a\u5df2\u51fa\u53f0\u5f3a\u5236\u6240\u6709\u72ac\u53ea\u690d\u5165\u82af\u7247\u7684\u653f\u7b56\u3002\u76ee\u6807\u662f\u52302007\u5e74\uff0c\u6240\u6709\u72ac\u53ea\u90fd\u690d\u5165\u6e05\u6670\u4e14\u5b89\u5168\u7684\u82af\u7247\u3002\u76ee\u524d\uff0c\u745e\u58eb\u7ea6\u670925%\u7684\u72ac\u53ea\u690d\u5165\u4e86\u82af\u7247\uff0c\u56e0\u4e3a\u5728\u745e\u58eb26\u4e2a\u5dde\u4e2d\uff0c\u67095\u4e2a\u5dde\u5f3a\u5236\u5b9e\u65bd\u4e86\u690d\u5165\u82af\u7247\u7684\u653f\u7b56\u3002\uff08\u52a8\u7269\u5236\u836f\uff09<br \/>\n&nbsp;<br \/>\n********************************************************************<br \/>\n\u519c\u4e1a\u5546\u4e1a\u65b0\u95fb<br \/>\n&nbsp;<br \/>\nCambria Biosciences LLC \u5ba3\u5e03\u4e0e\u4e16\u754c\u9886\u5148\u7684\u519c\u4e1a\u7efc\u5408\u4f01\u4e1a\u5148\u6b63\u8fbe\u6709\u9650\u516c\u53f8\u8fbe\u6210\u4e3a\u671f\u4e09\u5e74\u7684\u5408\u4f5c\u3002Cambria \u5c06\u5229\u7528\u5176\u6280\u672f\u9610\u660e\u5148\u6b63\u8fbe\u63d0\u4f9b\u7684\u5c0f\u5206\u5b50\u5316\u5408\u7269\u7684\u4f5c\u7528\u673a\u5236\uff0c\u4ee5\u6307\u5bfc\u65b0\u578b\u5b89\u5168\u6709\u6548\u7684\u6740\u866b\u5242\u7684\u7814\u53d1\u3002\u6839\u636e\u534f\u8bae\u6761\u6b3e\uff0c\u5148\u6b63\u8fbe\u5c06\u4e3a Cambria \u63d0\u4f9b\u8be5\u9879\u76ee\u7684\u5168\u90e8\u7814\u7a76\u8d44\u91d1\u548c\u90e8\u5206\u5b9e\u7269\u8d44\u6e90\u3002\u5177\u4f53\u8d22\u52a1\u6761\u6b3e\u5c1a\u672a\u62ab\u9732\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09<br \/>\n&nbsp; <br \/>\n********************************************************************<br \/>\nBRAKKE \u54a8\u8be2\u89c2\u70b9<br \/>\n&nbsp;<br \/>\n\u6b63\u5982\u9884\u671f\uff0c\u5927\u591a\u6570\u516c\u53f8\u4e0a\u534a\u5e74\u4e1a\u7ee9\u5f3a\u52b2\u3002\u867d\u7136\u8fd8\u6709\u534a\u5e74\u65f6\u95f4\uff0c\u4f46\u6211\u4eec\u8ba4\u4e3a\u4eca\u5e74\u5269\u4f59\u65f6\u95f4\u6ca1\u6709\u7406\u7531\u51fa\u73b0\u589e\u957f\u653e\u7f13\u3002\u6211\u4eec\u76f8\u4fe1\uff0c2004\u5e74\u5bf9\u5927\u591a\u6570\u516c\u53f8\u6765\u8bf4\u90fd\u5c06\u662f\u4e00\u4e2a\u589e\u957f\u4f18\u5f02\u7684\u4e00\u5e74\u3002\u795d\u8d3a\u60a8\u5de5\u4f5c\u51fa\u8272\u3002\u770b\u6765\uff0c\u6211\u4eec\u5c06\u83b7\u5f97\u5145\u8db3\u7684\u8d44\u91d1\u7528\u4e8e\u7814\u53d1\u548c\u4e1a\u52a1\u53d1\u5c55\u3002<br \/>\n&nbsp;<br \/>\n\u6211\u4eec\u5c06\u5728\u672c\u5468\u672b\u548c\u4e0b\u5468\u521d\u5728\u8d39\u57ce\u4e3e\u884c\u7684 AVMA \u4f1a\u8bae\u4e0a\u89c1\u5230\u4f60\u4eec\u3002<br \/>\n&nbsp;<br \/>\n\u795d\u5468\u672b\u6109\u5feb\u3002<br \/>\n&nbsp;<br \/>\n\u7f57\u6069\u00b7\u5e03\u62c9\u514b<\/p>\n<p>*******************************************************************<br \/>\n\u672c\u7535\u5b50\u901a\u8baf\u4e3a Brakke \u7684\u552f\u4e00\u8d22\u4ea7<br \/>\n\u54a8\u8be2\u6709\u9650\u516c\u53f8<br \/>\n\u5bf9\u672c\u6587\u5185\u5bb9\u7684\u4efb\u4f55\u4f7f\u7528\u5747\u987b\u7ecf<br \/>\n\u5e76\u6070\u5f53\u5730\u5f52\u529f\u4e8e Brakke Consulting, Inc.<br \/>\n\u6709\u5173 Brakke Consulting \u670d\u52a1\u7684\u66f4\u591a\u4fe1\u606f<br \/>\n\u548c\u8054\u5408\u7814\u7a76\uff0c\u8bf7\u8bbf\u95ee\u6211\u4eec\u7684\u7f51\u7ad9<br \/>\n<a href=\"https:\/\/brakkeconsulting.com\/zh\/\">www.brakkeconsulting.com<\/a>.<br \/>\n&nbsp;<br \/>\nBrakke \u54a8\u8be2\u516c\u53f8<br \/>\n2735 Villa Creek\uff0c\u5957\u623f 140<br \/>\n\u7f8e\u56fd\u5fb7\u514b\u8428\u65af\u5dde\u8fbe\u62c9\u65af 75234<\/p>\n<p>\u4e3a\u4e86\u63a5\u6536 HTML \u7248\u672c\u800c\u4e0d\u662f\u6587\u672c <br \/>\n\u5982\u9700\u67e5\u770b\u672c\u65b0\u95fb\u7a3f\u7684\u7248\u672c\uff0c\u8bf7\u4f7f\u7528\u672c\u65b0\u95fb\u7a3f\u5e95\u90e8\u7684\u94fe\u63a5<br \/>\n\u672c\u5468\u7684\u65f6\u4e8b\u901a\u8baf\u4e2d\u5199\u9053\uff1a\u201c\u5982\u679c\u4f60\u5e0c\u671b\u6211\u4eec<br \/>\n\u5c06\u60a8\u7684\u59d3\u540d\u4ece\u901a\u544a\u540d\u5355\u4e2d\u5220\u9664\uff0c\u6216\u8005\u5982\u679c\u60a8\u9700\u8981<br \/>\n\u66f4\u6539\u60a8\u7684\u4e2a\u4eba\u8d44\u6599\u6216\u7535\u5b50\u90ae\u4ef6\u5730\u5740\uff0c\u8bf7\u70b9\u51fb\u6b64\u5904\u201d\u3002<br \/>\n\u7136\u540e\u70b9\u51fb\u4f60\u7535\u5b50\u90ae\u4ef6\u5730\u5740\u4e0b\u65b9\u7684\u6309\u94ae<br \/>\nHTML\uff0c\u7136\u540e\u70b9\u51fb\u201c\u66f4\u65b0\u8ba2\u9605\u201d\u3002 <br \/>\n&nbsp;<br \/>\n\u5982\u679c\u60a8\u9700\u8981\u6709\u5173\u5783\u573e\u90ae\u4ef6\u8fc7\u6ee4\u5668\u5bf9\u63a5\u6536\u65b0\u95fb\u901a\u8baf\u7684\u5f71\u54cd\u7684\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee <a href=\"https:\/\/brakkeconsulting.com\/zh\/newsletter\/current.html\/\">https:\/\/brakkeconsulting.com\/newsletter\/current.html<\/a><\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>\u6253\u5370\u7248\u672c *********************************************************************** Brakke Consulting 2004 \u5e74 7 \u6708 23 \u65e5\u7684\u52a8\u7269\u4fdd\u5065\u65b0\u95fb\u548c\u7b14\u8bb0\u7248\u6743\u6240\u6709 \u00a9 Brakke Consulting, Inc. ****************************************************************** \u65b0\u95fb\u62a5\u9053\uff1a \u6536\u76ca\u65b0\u95fb\uff1a ABAXIS Elanco Fort Dodge Hill&#039;s IDEXX Immucell Intervet Neogen Nestle Novartis Pfizer Schering-Plough \u5176\u4ed6\u65b0\u95fb\uff1a Alpharma Bioproducts BioSentry Butler CattleSale CowTek DuPont Farmway Fort Dodge Genitrix Grain Processing Corp. Lextron Optibrand Pala-Tech Phoenix Scientific Phytopharm Spectrum Brands United Industries United Pet Group Yorkshire Animal Health ****************************************************************** \u516c\u53f8\u6536\u76ca\u62a5\u544a &gt; \u8f89\u745e\u516c\u53f8\u62a5\u544a\u4e86\u622a\u81f3 2004 \u5e74 6 \u6708 30 \u65e5\u7684\u4e09\u4e2a\u6708\u548c\u516d\u4e2a\u6708\u7684\u4e1a\u7ee9\u3002\u7b2c\u4e8c\u5b63\u5ea6\u5176\u52a8\u7269\u4fdd\u5065\u6536\u5165\u90e8\u95e8\u7684\u8425\u4e1a\u6536\u5165\u4e3a $4.84 \u4ebf\u6b27\u5143\uff0c\u4e0e 2003 \u5e74\u7b2c\u4e8c\u5b63\u5ea6\u76f8\u6bd4\u589e\u52a0\u4e86 26%\u3002\u4e0a\u534a\u5e74\u8425\u4e1a\u6536\u5165\u4e3a $9.12 \u4ebf\u6b27\u5143\uff0c\u4e0e 2003 \u5e74\u4e0a\u534a\u5e74\u76f8\u6bd4\u589e\u52a0\u4e86 40%\u3002\u8f89\u745e\u5bf9 Pharmacia \u7684\u6536\u8d2d\u4e8e 2003 \u5e74 4 \u6708 16 \u65e5\u5b8c\u6210\u3002\u9664\u4e86 Pharmacia \u6536\u8d2d\u7684\u5f71\u54cd\u5916\uff0cRimadyl\u3001Revolution \u548c Clavamox\/Synulox \u4ee5\u53ca\u725b\u751f\u7269\u5236\u54c1\u7684\u5f3a\u52b2\u8868\u73b0\uff0c\u4ee5\u53ca\u7f8e\u5143\u76f8\u5bf9\u4e8e\u4e0a\u5e74\u8d70\u5f31\u7684\u6709\u5229\u5f71\u54cd\u4e5f\u63a8\u52a8\u4e86\u4e1a\u7ee9\u7684\u589e\u957f\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09&gt; \u963f\u514b\u82cf\u8bfa\u8d1d\u5c14\u516c\u5e03\u4e86\u622a\u81f3 2004 \u5e74 6 \u6708 30 \u65e5\u7684\u7b2c\u4e09\u5b63\u5ea6\u548c\u516d\u4e2a\u6708\u7684\u4e1a\u7ee9\u3002\u52a8\u7269\u4fdd\u5065\u96c6\u56e2 Intervet \u5b9e\u73b0\u4e86 6% \u7684\u81ea\u4e3b\u589e\u957f\uff0c\u7b2c\u4e8c\u5b63\u5ea6\u7684\u9500\u552e\u989d\u4e3a 2.54 \u4ebf\u6b27\u5143\uff08$3.07 \u4ebf\u6b27\u5143\uff09<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/20053\/\" class=\"view-full-post-btn\">\u67e5\u770b\u5b8c\u6574\u6587\u7ae0<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-20053","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/zh\/20053\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"printer friendly version ******************************************************************* &nbsp;Brakke Consulting&rsquo;s &nbsp;Animal Health News &amp; Notes for July 23, 2004 &nbsp;Copyright &copy; Brakke Consulting, Inc. &nbsp;******************************************************************* IN THE NEWS: &nbsp; earnings news: ABAXIS Elanco Fort Dodge Hill&rsquo;s IDEXX Immucell Intervet Neogen Nestle Novartis Pfizer Schering-Plough &nbsp; &nbsp; other news: Alpharma Bioproducts BioSentry Butler CattleSale CowTek DuPont Farmway Fort Dodge Genitrix Grain Processing Corp. Lextron Optibrand Pala-Tech Phoenix Scientific Phytopharm Spectrum Brands United Industries United Pet Group Yorkshire Animal Health &nbsp; ****************************************************************** COMPANY EARNINGS RELEASES &nbsp; &gt;&nbsp; Pfizer reported results for the three and six month periods ended June 30, 2004.&nbsp; Second quarter revenues for its animal health division were $484 million, a 26% increase compared to the second quarter of 2003.&nbsp; First half revenues were $912 million, an increase of 40% compared to the first half of 2003.&nbsp; Pfizer&rsquo;s acquisition of Pharmacia was completed on April 16, 2003. In addition to the impact of the Pharmacia acquisition, results were driven by strong performances by Rimadyl, Revolution and Clavamox\/Synulox, and cattle biologicals, and by the favorable impact of a weaker US dollar relative to the prior year. (company website) &nbsp; &gt;&nbsp; Akzo Nobel announced results for the three and six month periods ended June 30, 2004. The animal health group Intervet achieved 6% autonomous growth, with sales of 254 million euros ($307 million) for the secondView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/zh\/20053\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2004-07-23T17:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-11T10:58:12+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"15 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/20053\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/20053\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for July 23, 2004\",\"datePublished\":\"2004-07-23T17:51:17+00:00\",\"dateModified\":\"2018-04-11T10:58:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/20053\/\"},\"wordCount\":2996,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/20053\/\",\"url\":\"https:\/\/brakkeconsulting.com\/ja\/20053\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#website\"},\"datePublished\":\"2004-07-23T17:51:17+00:00\",\"dateModified\":\"2018-04-11T10:58:12+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/20053\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/ja\/20053\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/20053\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/ja\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for July 23, 2004\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/ja\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/ja\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/zh\/20053\/","og_locale":"zh_CN","og_type":"article","og_title":"News from Brakke Consulting","og_description":"printer friendly version ******************************************************************* &nbsp;Brakke Consulting&rsquo;s &nbsp;Animal Health News &amp; Notes for July 23, 2004 &nbsp;Copyright &copy; Brakke Consulting, Inc. &nbsp;******************************************************************* IN THE NEWS: &nbsp; earnings news: ABAXIS Elanco Fort Dodge Hill&rsquo;s IDEXX Immucell Intervet Neogen Nestle Novartis Pfizer Schering-Plough &nbsp; &nbsp; other news: Alpharma Bioproducts BioSentry Butler CattleSale CowTek DuPont Farmway Fort Dodge Genitrix Grain Processing Corp. Lextron Optibrand Pala-Tech Phoenix Scientific Phytopharm Spectrum Brands United Industries United Pet Group Yorkshire Animal Health &nbsp; ****************************************************************** COMPANY EARNINGS RELEASES &nbsp; &gt;&nbsp; Pfizer reported results for the three and six month periods ended June 30, 2004.&nbsp; Second quarter revenues for its animal health division were $484 million, a 26% increase compared to the second quarter of 2003.&nbsp; First half revenues were $912 million, an increase of 40% compared to the first half of 2003.&nbsp; Pfizer&rsquo;s acquisition of Pharmacia was completed on April 16, 2003. In addition to the impact of the Pharmacia acquisition, results were driven by strong performances by Rimadyl, Revolution and Clavamox\/Synulox, and cattle biologicals, and by the favorable impact of a weaker US dollar relative to the prior year. (company website) &nbsp; &gt;&nbsp; Akzo Nobel announced results for the three and six month periods ended June 30, 2004. The animal health group Intervet achieved 6% autonomous growth, with sales of 254 million euros ($307 million) for the secondView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/zh\/20053\/","og_site_name":"Brakke Consulting Website","article_published_time":"2004-07-23T17:51:17+00:00","article_modified_time":"2018-04-11T10:58:12+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Brakke Consulting","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"15 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/ja\/20053\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/ja\/20053\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for July 23, 2004","datePublished":"2004-07-23T17:51:17+00:00","dateModified":"2018-04-11T10:58:12+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/ja\/20053\/"},"wordCount":2996,"articleSection":["Newsletter"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/ja\/20053\/","url":"https:\/\/brakkeconsulting.com\/ja\/20053\/","name":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/ja\/#website"},"datePublished":"2004-07-23T17:51:17+00:00","dateModified":"2018-04-11T10:58:12+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/ja\/20053\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/ja\/20053\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/ja\/20053\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/ja\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for July 23, 2004"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/ja\/#website","url":"https:\/\/brakkeconsulting.com\/ja\/","name":"Brakke\u54a8\u8be2\u7f51\u7ad9","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/ja\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"\u5e03\u62c9\u514b\u54a8\u8be2\u516c\u53f8","url":"https:\/\/brakkeconsulting.com\/zh\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/20053","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/comments?post=20053"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/20053\/revisions"}],"predecessor-version":[{"id":20190,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/20053\/revisions\/20190"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/media?parent=20053"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/categories?post=20053"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/tags?post=20053"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}